EMA recommends authorisation of booster doses of Comirnaty from 12 years of age

25 febbraio 2022 – EMA’s human medicines committee (CHMP) has recommended that a booster dose of the COVID-19 vaccine Comirnaty may be given where appropriate to adolescents from 12 years of age. Comirnaty is already authorised in the EU as a 2-dose primary course in adolescents (as well as adults and children from 5 years of age) and a booster dose is currently authorised from 18 years of age.

For more information, see here.